» Articles » PMID: 14990712

Human Macrophage C-type Lectin Specific for Galactose and N-acetylgalactosamine Promotes Filovirus Entry

Overview
Journal J Virol
Date 2004 Mar 3
PMID 14990712
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

Filoviruses cause lethal hemorrhagic disease in humans and nonhuman primates. An initial target of filovirus infection is the mononuclear phagocytic cell. Calcium-dependent (C-type) lectins such as dendritic cell- or liver/lymph node-specific ICAM-3 grabbing nonintegrin (DC-SIGN or L-SIGN, respectively), as well as the hepatic asialoglycoprotein receptor, bind to Ebola or Marburg virus glycoprotein (GP) and enhance the infectivity of these viruses in vitro. Here, we demonstrate that a recently identified human macrophage galactose- and N-acetylgalactosamine-specific C-type lectin (hMGL), whose ligand specificity differs from DC-SIGN and L-SIGN, also enhances the infectivity of filoviruses. This enhancement was substantially weaker for the Reston and Marburg viruses than for the highly pathogenic Zaire virus. We also show that the heavily glycosylated, mucin-like domain on the filovirus GP is required for efficient interaction with this lectin. Furthermore, hMGL, like DC-SIGN and L-SIGN, is present on cells known to be major targets of filoviruses (i.e., macrophages and dendritic cells), suggesting a role for these C-type lectins in viral replication in vivo. We propose that filoviruses use different C-type lectins to gain cellular entry, depending on the cell type, and promote efficient viral replication.

Citing Articles

Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.

Wang S, Li W, Wang Z, Yang W, Li E, Xia X Signal Transduct Target Ther. 2024; 9(1):223.

PMID: 39256346 PMC: 11412324. DOI: 10.1038/s41392-024-01917-x.


Genome-wide CRISPR/Cas9 screen identifies SLC39A9 and PIK3C3 as crucial entry factors for Ebola virus infection.

Gong M, Peng C, Yang C, Wang Z, Qian H, Hu X PLoS Pathog. 2024; 20(8):e1012444.

PMID: 39173055 PMC: 11341029. DOI: 10.1371/journal.ppat.1012444.


Fully human monoclonal antibodies against Ebola virus possess complete protection in a hamster model.

Li W, Yang W, Liu X, Zhou W, Wang S, Wang Z Emerg Microbes Infect. 2024; 13(1):2392651.

PMID: 39155772 PMC: 11348817. DOI: 10.1080/22221751.2024.2392651.


Characterization of human tibrovirus envelope glycoproteins.

Munyeku-Bazitama Y, Saito T, Hattori T, Miyamoto H, Lombe B, Mori-Kajihara A J Virol. 2024; 98(7):e0049924.

PMID: 38953631 PMC: 11265436. DOI: 10.1128/jvi.00499-24.


Gastrointestinal dysmotility in rodent models of Parkinson's disease.

Pellegrini C, Travagli R Am J Physiol Gastrointest Liver Physiol. 2024; 326(4):G345-G359.

PMID: 38261717 PMC: 11212145. DOI: 10.1152/ajpgi.00225.2023.


References
1.
Volchkov V, Becker S, Volchkova V, Ternovoj V, Kotov A, Netesov S . GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology. 1995; 214(2):421-30. DOI: 10.1006/viro.1995.0052. View

2.
Baribaud F, Pohlmann S, Leslie G, Mortari F, Doms R . Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J Virol. 2002; 76(18):9135-42. PMC: 136426. DOI: 10.1128/jvi.76.18.9135-9142.2002. View

3.
Sanchez A, Trappier S, Mahy B, Peters C, Nichol S . The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A. 1996; 93(8):3602-7. PMC: 39657. DOI: 10.1073/pnas.93.8.3602. View

4.
Davis K, Anderson A, Geisbert T, Steele K, Geisbert J, Vogel P . Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch Pathol Lab Med. 1997; 121(8):805-19. View

5.
Takada A, Robison C, Goto H, Sanchez A, Murti K, Whitt M . A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A. 1998; 94(26):14764-9. PMC: 25111. DOI: 10.1073/pnas.94.26.14764. View